Pravastatin

Immunotag™ PRLHR Antibody-Biotin*

Immunotag™ PRLHR Antibody-Biotin*

Immunotag™ PRPH2 Antibody-Biotin*

Immunotag™ PRPH2 Antibody-Biotin*

A staurosporine analog that potently inhibits JAK2 kinase (IC₅₀ = 1 nM) and downstream targets STAT5 (IC₅₀ = 10-30 nM) and STAT3 in a human erythroleukemic cell line expressing the JAK2V617F mutation potently inhibits the

A staurosporine analog that potently inhibits JAK2 kinase (IC₅₀ = 1 nM) and downstream targets STAT5 (IC₅₀ = 10-30 nM) and STAT3 in a human erythroleukemic cell line expressing the JAK2V617F mutation potently inhibits the

A staurosporine analog that potently inhibits JAK2 kinase (IC₅₀ = 1 nM) and downstream targets STAT5 (IC₅₀ = 10-30 nM) and STAT3 in a human erythroleukemic cell line expressing the JAK2V617F mutation potently inhibits the

A staurosporine analog that potently inhibits JAK2 kinase (IC₅₀ = 1 nM) and downstream targets STAT5 (IC₅₀ = 10-30 nM) and STAT3 in a human erythroleukemic cell line expressing the JAK2V617F mutation potently inhibits the

General description Monoclonal Anti-ADFP/PLIN2 (mouse IgG1 isotype) is derived from the hybridoma ADFP-5 produced by the fusion of mouse myeloma cells and splenocytes from BALB/c mice immunized with a synthetic peptide. Perilipin 2 (PLIN2) is a

General description Paeoniflorin has been demonstrated to exert anti-inflammatory and immunomodulatory effects. Application Paeoniflorin was used to treat rats with collagen-induced arthritis in a study to assess the pro-apoptotic effect of

Biochem/physiol Actions PF-03491165 is a potent HMG-CoA reductase inhibitor (IC50 = 0.1 nM) with good hepatoselectivity (rat hepatocyte/myocyte cholesterol synthesis IC50 = 0.

Biochem/physiol Actions PF-03491165 is a potent HMG-CoA reductase inhibitor (IC50 = 0.1 nM) with good hepatoselectivity (rat hepatocyte/myocyte cholesterol synthesis IC50 = 0.